Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MAbs to lymphocyte/endothelial adhesion molecules prevent diabetes in mouse model

Dec. 2, 1997

Muse approved in U.K.

Dec. 2, 1997

Further labeling changes for Rezulin/Noscal; Romozin availability suspended in U.K.

Dec. 2, 1997

AHP describes new compounds with tissue-selective estrogenic and antiestrogenic effects

Dec. 1, 1997

Sankyo discloses agents for diabetes and related complications

Nov. 28, 1997

Lilly prepares new benzothiophenes

Nov. 28, 1997

New approvals for Menorest

Nov. 28, 1997

Negative phase II results for long-term risedronate in osteoporosis

Nov. 28, 1997

Launch of Ligand/Lilly metabolic disease alliance

Nov. 27, 1997

Agents activating beta3-adrenoceptors from Pfizer

Nov. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...